| NCT Number | NCT03017326 |
| Lead Sponsor | University of Birmingham
Collaborators: Fundació Institut Germans Trias i Pujol, University Hospital Munich, University Hospital, Bonn, University of Kiel, University Hospital Tuebingen, University of Padova, Ludwig-Maximilians - University of Munich, Medical University of Gdansk, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Motol University Hospital, Rennes University Hospital, Children's University Hospital, Ireland, University of Oslo, Princess Maxima Center for Pediatric Oncology, Andaluz Health Service, Swiss Pediatric Oncology Group, Gothia Forum - Center for Clinical Trial, The Leeds Teaching Hospitals NHS Trust, Bambino Gesù Hospital and Research Institute, Newcastle University, Experimental Cancer Medicine Centres, XenTech, Evry |
| Conditions | Hepatoblastoma, Carcinoma, Hepatocellular |
| Enrollment | 450 participants |
| Start Date | 2017-08-24 |
| Primary Completion | 2026-12-31 (estimated) |
| Study Completion | 2027-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-13 |